PATENT CLAIM ANALYSIS

Application Number: 15903785
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "171000"]

Abstract:
Topical pharmaceutical compositions comprise a combination of a corticosteroid and a retinoid; and methods for treating psoriasis with same. In one embodiment, the corticosteroid comprises halobetasol propionate, and the retinoid comprises tazarotene.

Claim (Index 2):
The method of  claim 1 , wherein said applying is carried out once per day for eight weeks.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.37037
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15173961', '15621325', '15209716', '14463985', '13921833']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7286231700079551
- 35 USC 102 Novelty (BERT): 0.5454816056103473
- Combined Prediction Score: 0.7103090135681943
- Mean Citation Score: 221.16387000000003
- Max Citation Score: 374.73453
- Similarity Product: 208.23437354215625

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test